Development and validation of osteoporosis prescreening model for Iranian postmenopausal women

被引:3
|
作者
Matin N. [1 ]
Tabatabaie O. [1 ]
Keshtkar A. [2 ]
Yazdani K. [3 ]
Asadi M. [4 ]
机构
[1] School of Medicine, Tehran University of Medical Sciences, Tehran
[2] Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran
[3] Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran
[4] Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran
关键词
Holdout validation; Logistic regression; Osteoporosis; Prescreening; Scoring;
D O I
10.1186/s40200-015-0140-7
中图分类号
学科分类号
摘要
Background: Studies have indicated that the commonly used osteoporosis prescreening tools are not appropriate for use in every nation. This study was designed to develop and validate a prescreening model for bone mineral densitometry among Iranian postmenopausal women. Methods: From 13613 individuals who were referred for bone mineral densitometry in Shariati hospital in Tehran, 8644 postmenopausal women were considered for the study after excluding men and premenopausal women. Questionnaires regarding the risk factors for osteoporosis were filled for each individual. Bone mineral density at the lumbar vertebrae (L2-L4), femoral neck and total femur was measured by dual X-ray absorptiometry. Using holdout validation, the study sample was divided into two parts; training set (5705) and test set (2939). Logistic regression analysis was performed on the training set. A scoring model was developed and tested in the test set. Results: Based on the training set, a seven-variable model named OPMIP (Osteoporosis Prescreening Model for Iranian Postmenopausal women) was developed with C statistics (area under curve) of 0.72. Using a cut-off of -2.5 for the model, the sensitivity, specificity, positive predictive value and negative predictive value were 72%, 59.5%, 64% and 69% respectively. The model performance was tested in the test set. OPMIP correctly classified 67.10% of cases with a sensitivity and specificity of 73.2% and 61%. Conclusions: In order to appropriately refer patients for a bone mineral densitometry, OPMIP can be used as a prescreening tool in Iranian Postmenopausal women. © 2015 Matin et al.
引用
收藏
相关论文
共 50 条
  • [21] Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density
    Salaffi, F
    Silveri, F
    Stancati, A
    Grassi, W
    [J]. CLINICAL RHEUMATOLOGY, 2005, 24 (03) : 203 - 211
  • [22] Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density
    Fausto Salaffi
    Ferdinando Silveri
    Andrea Stancati
    Walter Grassi
    [J]. Clinical Rheumatology, 2005, 24 : 203 - 211
  • [23] Osteoporosis in postmenopausal women
    Pluskiewicz, W
    Drozdzowska, B
    Halaba, Z
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2002, 52 (479): : 496 - 496
  • [24] Osteoporosis in postmenopausal women
    Malmartel, Alexandre
    [J]. EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2022, (181): : 121 - 123
  • [25] Osteoporosis in postmenopausal women
    Saryazdi, Mohammad Ali Falahzadeh
    Mojibian, M.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 : 121 - 122
  • [26] Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
    Przerwa, Filip
    Uzar, Izabela
    Bogacz, Anna
    Kotrych, Katarzyna
    Sulikowski, Tadeusz
    Wolek, Marlena
    Kaminski, Adam
    Zietek, Pawel
    Czerny, Boguslaw
    [J]. BIOMEDICINES, 2023, 11 (12)
  • [27] OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    RENNER, RP
    BOUCHER, LJ
    KAUFMAN, HW
    [J]. JOURNAL OF PROSTHETIC DENTISTRY, 1984, 52 (04): : 581 - 588
  • [28] The development of tibolone for prevention and treatment of osteoporosis in postmenopausal women
    Lindsay, R.
    Ederveen, A. G.
    Gallagher, J. C.
    Delmas, P. D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S361 - S362
  • [29] IDENTIFICATION AND TREATMENT OF POSTMENOPAUSAL WOMEN AT RISK FOR THE DEVELOPMENT OF OSTEOPOROSIS
    DOREN, M
    SCHNEIDER, HPG
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (11) : 431 - 433
  • [30] Osteoporosis in postmenopausal women
    Moe, Samantha
    Paige, Allison
    Allan, G. Michael
    [J]. CANADIAN FAMILY PHYSICIAN, 2021, 67 (05) : 346 - 346